CDE

SRX HEALTH SOLUTIONS INC. CELEBRATES ADDITION OF NEW PHARMACY IN COQUITLAM, BC.

Retrieved on: 
Tuesday, October 31, 2023

TORONTO, Oct. 31, 2023 /CNW/ - SRx Health Solutions Inc. ("SRx" or the "Company") Expands Its Reach and Services with Mediglen Pharmacy & Compounding ("Mediglen") Partnership.

Key Points: 
  • TORONTO, Oct. 31, 2023 /CNW/ - SRx Health Solutions Inc. ("SRx" or the "Company") Expands Its Reach and Services with Mediglen Pharmacy & Compounding ("Mediglen") Partnership.
  • SRx, a leading healthcare provider, is pleased to announce that Mediglen Pharmacy & Compounding ("Mediglen"), a well-respected pharmacy centrally located in the city of Coquitlam, British Columbia, have joined the Companies network.
  • "The partnership marks another instrumental milestone towards accomplishing our goal to make specialty pharmacy services and integrated care more accessible," stated Adesh Vora, the Company's Chief Executive Officer.
  • As stated by Arash Pourzare, PharmD, RPh, CDE, Owner/Manager of Mediglen, "Joining SRx means bringing a revolutionary patient-focused approach to our beloved Coquitlam community.

ProjectReady Now Automates Procore Site Creation

Retrieved on: 
Thursday, October 26, 2023

WHITE PLAINS, N.Y., Oct. 26, 2023 /PRNewswire/ -- ProjectReady, a leading provider of collaborative project information management software for Architecture, Engineering, and Construction (AEC) projects today announced a new automated site setup feature marking a significant milestone within its involvement on the Procore App Marketplace. Procore Technologies, Inc. a leading global provider of construction management software, launched the Procore App Marketplace in 2016 as an online hub for third-party integrations and custom applications modernizing the everyday lives of construction professionals. This expanded solution further simplifies setup and connection of project systems, platforms, and common data environments (CDEs) while reducing administrative overhead and rework.

Key Points: 
  • Automated Creation and Connection of Procore Project Sites In ProjectReady Streamlines New Project Setup, Removes Administrative Overhead
    WHITE PLAINS, N.Y., Oct. 26, 2023 /PRNewswire/ -- ProjectReady , a leading provider of collaborative project information management software for Architecture, Engineering, and Construction (AEC) projects today announced a new automated site setup feature marking a significant milestone within its involvement on the Procore App Marketplace .
  • ProjectReady's automated Procore project setup solution offers a greater level of efficiency and convenience for AEC professionals and project owners.
  • Automated Procore project provisioning with ProjectReady gives teams a seamless process for setting up new projects, Modi-Oza continued.
  • In a matter of minutes, a project team can gain access to a project-specific site in Procore, a secure SharePoint site, Microsoft 365 group email, Microsoft Team, and instant connectivity to other systems, including the Autodesk Construction Cloud.

Boost Efficiency and Policyholder Satisfaction with Assurant’s New Guidewire Marketplace Apps

Retrieved on: 
Wednesday, October 25, 2023

Now, those solutions, HOIVerify℠ and Carrier Direct Endorsement℠, can be integrated with Guidewire to elevate insurer efficiency.

Key Points: 
  • Now, those solutions, HOIVerify℠ and Carrier Direct Endorsement℠, can be integrated with Guidewire to elevate insurer efficiency.
  • Assurant’s HOIVerify℠ Accelerator for PolicyCenter facilitates automatic data exchange between insurers and mortgage servicers to decrease required manual data exchange for all involved parties, increasing policyholder satisfaction.
  • Integrating them with Guidewire only serves to improve efficiency and ease for insurers even further.”
    Assurant is a “New to Connections” sponsor of Guidewire Connections 2023 .
  • For more information on the integration, visit the Assurant booth (N6) at Connections.

Qilu Pharmaceutical announces the latest results from its clinical study on QL1706, in combination with chemotherapy, as a first-line treatment for recurrent or metastatic cervical cancer

Retrieved on: 
Wednesday, October 25, 2023

This trial studied the use of QL1706 (iparomlimab and tuvonralimab) in combination with chemotherapy, with or without bevacizumab, as a first-line treatment of recurrent or metastatic cervical cancer (r/mCC).

Key Points: 
  • This trial studied the use of QL1706 (iparomlimab and tuvonralimab) in combination with chemotherapy, with or without bevacizumab, as a first-line treatment of recurrent or metastatic cervical cancer (r/mCC).
  • Moreover, the treatment exhibited a manageable safety profile without any new safety signals observed, making it a potential new first-line treatment option for r/mCC patients.
  • Currently, the preferred standard first-line treatment for r/mCC patients is cisplatin or carboplatin and paclitaxel plus bevacizumab, and efficacy and safety of the treatment also need to be considered.
  • For r/mCC patients with positive PD-L1 expression, the PD-1 inhibitor pembrolizumab, administered with chemotherapy and with or without bevacizumab, is recommended as the standard first-line treatment.

Qilu Pharmaceutical announces the latest results from its clinical study on QL1706, in combination with chemotherapy, as a first-line treatment for recurrent or metastatic cervical cancer

Retrieved on: 
Wednesday, October 25, 2023

This trial studied the use of QL1706 (iparomlimab and tuvonralimab) in combination with chemotherapy, with or without bevacizumab, as a first-line treatment of recurrent or metastatic cervical cancer (r/mCC).

Key Points: 
  • This trial studied the use of QL1706 (iparomlimab and tuvonralimab) in combination with chemotherapy, with or without bevacizumab, as a first-line treatment of recurrent or metastatic cervical cancer (r/mCC).
  • Moreover, the treatment exhibited a manageable safety profile without any new safety signals observed, making it a potential new first-line treatment option for r/mCC patients.
  • Currently, the preferred standard first-line treatment for r/mCC patients is cisplatin or carboplatin and paclitaxel plus bevacizumab, and efficacy and safety of the treatment also need to be considered.
  • For r/mCC patients with positive PD-L1 expression, the PD-1 inhibitor pembrolizumab, administered with chemotherapy and with or without bevacizumab, is recommended as the standard first-line treatment.

Enhanced Community Development Awarded $40 Million in New Markets Tax Credit Allocation from U.S. Treasury Department

Retrieved on: 
Tuesday, October 17, 2023

NEW YORK, Oct. 17, 2023 /PRNewswire/ -- Enhanced Community Development, a subsidiary of Enhanced Capital, announced that it has been awarded $40 million in New Markets Tax Credits (NMTC) allocation.

Key Points: 
  • NEW YORK, Oct. 17, 2023 /PRNewswire/ -- Enhanced Community Development, a subsidiary of Enhanced Capital, announced that it has been awarded $40 million in New Markets Tax Credits (NMTC) allocation.
  • This award marks the ninth time Enhanced Community Development has received a federal NMTC allocation, resulting in a cumulative total of $430 million in federal NMTC allocation since 2006.
  • The U.S. Treasury Department's Community Development Financial Institutions (CDFI) Fund announced the allocation to Enhanced Capital as part of a $5 billion award to 102 Community Development Entities (CDEs) in the 2022 round of the NMTC Program.
  • "Enhanced Community Development's New Markets Tax Credit award amplifies our mission of stimulating jobs and growth in small businesses and providing community services in economically underserved urban and rural areas," highlighted Catherine Blume, Vice President at Enhanced Capital.

Leading provider of global wellbeing solutions addresses mental health stigma and inequities head-on with World Mental Health Day campaigns

Retrieved on: 
Monday, October 9, 2023

RALEIGH, N.C., Oct. 09, 2023 (GLOBE NEWSWIRE) -- Workplace Options (WPO), the world’s largest independent provider of holistic wellbeing solutions, is tackling the persistent stigma that surrounds mental health and help-seeking in a new booklet released as part of the organization’s campaign for this year’s World Mental Health Day. The booklet, which explores the harmful impact of mental health stigma on employees’ wellbeing and their willingness to seek help—including its global implications—coincides with the theme for this year's event, which promotes mental health as a “universal human right.”

Key Points: 
  • 450 million people currently cope with mental health issues.
  • RALEIGH, N.C., Oct. 09, 2023 (GLOBE NEWSWIRE) -- Workplace Options (WPO), the world’s largest independent provider of holistic wellbeing solutions, is tackling the persistent stigma that surrounds mental health and help-seeking in a new booklet released as part of the organization’s campaign for this year’s World Mental Health Day.
  • Honoring this message, WPO’s booklet highlights current disparities in access to mental health services.
  • The conference will also include a panel discussion on how to champion DEIB in the workplace.

Coeur Announces Third Quarter 2023 Earnings Call

Retrieved on: 
Tuesday, October 10, 2023

Coeur Mining, Inc. (“Coeur” or the “Company”) (NYSE: CDE) today announced that it will report its third quarter 2023 operational and financial results after the New York Stock Exchange closes for trading on Wednesday, November 8, 2023.

Key Points: 
  • Coeur Mining, Inc. (“Coeur” or the “Company”) (NYSE: CDE) today announced that it will report its third quarter 2023 operational and financial results after the New York Stock Exchange closes for trading on Wednesday, November 8, 2023.
  • The Company will be hosting a conference call at 11:00 a.m. Eastern Time (10:00 a.m. Central Time) on Thursday, November 9, 2023.
  • Hosting the call will be Mitchell J. Krebs, President and Chief Executive Officer of Coeur, who will be joined by Thomas S. Whelan, Senior Vice President and Chief Financial Officer, Michael “Mick” Routledge, Senior Vice President and Chief Operating Officer, Aoife McGrath, Senior Vice President of Exploration, and other members of management.
  • A replay of the call will be available through November 16, 2023.

Truist receives $65 million New Markets Tax Credit allocation to support communities across the U.S.

Retrieved on: 
Friday, October 13, 2023

As part of the program, Truist provides loans and investments with reduced interest rates and/or non-traditional terms and conditions to support community development projects.

Key Points: 
  • As part of the program, Truist provides loans and investments with reduced interest rates and/or non-traditional terms and conditions to support community development projects.
  • "Truist has been active in the NMTC Program for many years and we're proud to have been trusted with more than $750 million in allocation authority, to date," said Jamise Goodman, NMTC program director for Truist Community Development Enterprises.
  • Through its investments in community development projects, Truist Community Capital works to ensure access to services and amenities that directly benefit neighborhoods and residents.
  • "This new round of allocation will build on the impactful investments Truist is making to enhance neighborhoods, support residents and improve access to vital services."

U.S. Bank Receives $55 Million in New Markets Tax Credit Allocation

Retrieved on: 
Friday, September 29, 2023

U.S. Bancorp Impact Finance, a subsidiary of U.S. Bank, and its community development entity (CDE) – USBCDE, LLC – received $55 million of New Markets Tax Credit (NMTC) allocation from the U.S. Department of Treasury.

Key Points: 
  • U.S. Bancorp Impact Finance, a subsidiary of U.S. Bank, and its community development entity (CDE) – USBCDE, LLC – received $55 million of New Markets Tax Credit (NMTC) allocation from the U.S. Department of Treasury.
  • The allocation is part of the federal government’s $5 billion NMTC program, which helps economically distressed communities attract private investment capital.
  • USBCDE, LLC has now been awarded more than $1 billion in total allocations, one of only three CDEs to do so.
  • It is one of 102 CDEs to receive a share of the NMTC allocation authority package announced by the Treasury’s Community Development Financial Institutions Fund (CDFI Fund).